0030

Daewoong Co., Ltd. (003090)

Market Closed
12 Dec, 06:30
KRX SM KRX SM
24,150. 00
-700
-2.82%
1.01T Market Cap
- P/E Ratio
800% Div Yield
103,182 Volume
- Eps
24,850
Previous Close
Day Range
23,900 25,200
Year Range
17,420 28,850
Want to track 003090 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 58 days

Summary

003090 closed yesterday lower at ₩24,150, a decrease of 2.82% from Thursday's close, completing a monthly decrease of -3.98% or ₩1,000. Over the past 12 months, 003090 stock gained 13.11%.
The next announced payment will be in In 4 months on Apr 13, 2026 for a total of ₩200.
The last earnings report, released on Nov 12, 2025, exceeded the consensus estimates by 981.49%. On average, the company has surpassed earnings expectations by 857.41%, based on the last three reports. The next scheduled earnings report is due on Feb 09, 2026.
Daewoong Co., Ltd. has completed 1 stock splits, with the recent split occurring on Apr 26, 2017.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).

003090 Chart

Similar

Cheil Bio Co., Ltd.
3,120,059.25
0%
Hyundai Motor Co.
302,000
+2.2%
Hyundai Motor Co. Ltd.
204,000
+2.05%
Hyundai Motor Co. Ltd. Preferred
207,000
+2.22%
Hyundai Motor Co., Ltd. Preferred
209,500
+2.44%

Daewoong Co., Ltd. (003090) FAQ

What is the stock price today?

The current price is ₩24,150.00.

On which exchange is it traded?

Daewoong Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 003090.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 800%.

What is its market cap?

As of today, the market cap is 1.01T.

When is the next earnings date?

The next earnings report will release on Feb 09, 2026.

Has Daewoong Co., Ltd. ever had a stock split?

Daewoong Co., Ltd. had 1 splits and the recent split was on Apr 26, 2017.

Daewoong Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Yeong-Hwan Yoon CEO
KRX SM Exchange
KR7003090008 ISIN
KR Country
379 Employees
29 Dec 2025 Last Dividend
26 Apr 2017 Last Split
- IPO Date

Overview

Daewoong Co., Ltd., formerly known as Daewoong Pharmaceutical Co., Ltd., is a significant player in the pharmaceutical industry, primarily operating in South Korea. Since its establishment in 1945, the company has expanded its horizons beyond pharmaceutical manufacturing and sales to include a varied portfolio of services and products. With its headquarters located in Seongnam, South Korea, Daewoong Co., Ltd. has shown adaptability and growth by venturing into real estate rental, lifestyle disease prevention research, business management, public affairs, and facility management sectors. The historical name change in 2002 from Daewoong Pharmaceutical Co., Ltd. to Daewoong Co., Ltd. reflects the company’s evolution and diversification into various businesses beyond its original pharmaceutical roots.

Products and Services

  • Manufacture and Sale of Pharmaceuticals

    Daewoong Co., Ltd. is primarily engaged in developing, manufacturing, and marketing a wide range of pharmaceutical products. This includes prescription drugs, over-the-counter medications, and other healthcare solutions, focusing on improving patient healthcare and outcomes.

  • Real Estate Rental Business

    In addition to its pharmaceutical operations, Daewoong has diversified into the real estate market, offering rental services. This business segment underscores the company's strategic expansion into stable, income-generating real estate investments.

  • Lifestyle-related Disease Prevention Research

    The company dedicates a portion of its operations to research focused on preventing lifestyle-related diseases. This initiative aligns with its core mission of enhancing healthcare and reflects its commitment to addressing modern health challenges through innovation.

  • Business Management Services

    Daewoong Co., Ltd. offers expertise in business management services, facilitating efficient operational, financial, and strategic planning processes for businesses. This service complements its core pharmaceutical operations and allows for a broader impact on the business sector.

  • Public Affairs and Facility Management Services

    The company provides public affairs and facility management services, showcasing its ability to offer comprehensive support services to ensure the smooth operation of various facilities. This diversification signifies the company's adaptability and desire to meet a broad array of client needs.

  • Processing and Sale of Food Products

    Expanding its portfolio further, Daewoong Co., Ltd. also ventures into the food industry with the processing and sale of food products. This move represents a strategic step towards leveraging its expertise in health and wellness into related food markets, acknowledging the strong link between pharmaceuticals and nutrition.

Contact Information

Address: 244 Galmachi-ro, Seongnam, South Korea
Phone: 82 2 550 8800